Partners
Healthcare Professionals
Partners
Healthcare Professionals
Atrantil for Healthcare Professionals
A Gastroenterologist-Developed, Polyphenol-Powered Approach for Bloating, Methane-Associated Digestive Imbalance, Dysbiosis, and Gut Barrier Support
Atrantil was developed by Dr. Ken Brown after years of seeing patients struggling with:
that often did not respond to:
The goal was never simply symptom masking. The goal was understanding why the bloating was happening in the first place.
Atrantil products are designed to work at the level of:
Information on this page is intended for healthcare professionals practicing in the United States.
We currently offer two practitioner-focused products, that are:
| Atrantil® | Atrantil PRO |
|---|---|
| Methane-associated bloating | Broader microbiome restoration |
| Small intestine focused | Colon + barrier support |
| Fermentation + methane pathways | Dysbiosis + gut barrier integrity |
| First-line digestive support | More complex microbiome cases |
| Gas pressure + constipation | Post-antibiotic + inflammatory support |
Atrantil®
Designed for:
Atrantil focuses primarily on the small intestine and duodenal environment.
Atrantil PRO
Atrantil PRO combines the Atrantil polyphenol blend with three soil-based spore biotics selected specifically to work synergistically with the polyphenols.
Designed for patients with:
Atrantil PRO expands support beyond methane-associated bloating into broader microbiome restoration and intestinal barrier support.
Atrantil may be appropriate for patients experiencing:
Atrantil is often used:
Atrantil PRO may be more appropriate for patients experiencing:
The original Atrantil primarily focuses on:
Atrantil PRO expands that support deeper into:
Atrantil is a patented combination of three natural botanical extracts designed to work together within the small intestine.The focus is mechanism-first:
The first botanical, peppermint leaf, acts as a natural antispasmodic.¹²
Research suggests peppermint may help:
This allows the other ingredients more time to interact within the gut lumen.
Related Reading:
The second botanical, quebracho colorado, contains tannin-rich polyphenols called proanthocyanidins.¹³
Research suggests these polyphenols may:
In simple terms?
Atrantil targets the environment methane-associated microbes depend on.This became one of the foundational mechanisms behind the formulation.
Related Reading:
Podcast Cross Reference: Dr. Kenneth Brown discusses methane, fermentation, and microbial gas production in more detail on The Gut Check Project podcast. Available on: Spotify YouTube Apple Podcasts
The third botanical, horse chestnut seed extract, contains aescin, a membrane-active saponin complex.¹⁴
Research suggests aescin may:
Together, the three ingredients were selected for different jobs:
Three ingredients. Three different jobs. One coordinated formula.
On top of the original Atrantil mechanism, the added soil-based spore biotics in Atrantil PRO have been studied for their ability to:
Butyrate is one of the primary fuel sources for colon cells.It plays an important role in:
Low butyrate production has been associated with:
The spore biotics in Atrantil PRO help support microbial environments associated with healthier butyrate production.
One of the key microbial targets in Atrantil PRO is: Akkermansia muciniphila.
This bacterium has become increasingly studied for its relationship to:
Research suggests healthier levels of Akkermansia may be associated with improved intestinal barrier function and broader digestive resilience.
This is where the formulation becomes especially interesting. Atrantil’s tannin-rich polyphenols are broken down into smaller phenolic compounds through enzymes produced by the spore biotics, including tannase activity. Those smaller phenolic compounds may then act as prebiotic fuel for beneficial microbes deeper in the colon. In simple terms, spore biotics help unlock additional downstream activity in polyphenols. At the same time:
The goal is not simply to add bacteria. The goal is to create conditions that support a healthier, more diverse microbiome over time.
Research suggests the spore strains may help reinforce intestinal barrier integrity and reduce permeability associated with “leaky gut.”This includes support for:
Lipopolysaccharide (LPS) is an endotoxin associated with inflammatory signaling and microbiome imbalance.Research suggests spore biotics may help:
The combination of polyphenols and spore biotics may also support NRF2 activation, one of the body’s major antioxidant regulatory pathways.
In simple terms?
This helps support the body’s natural antioxidant defense systems and may help reduce oxidative stress within the gut environment.
One of the biggest challenges in dysbiosis is bacterial biofilm formation.Biofilms help protect unwanted microbes from:
Research suggests tannin-rich polyphenols may help interfere with biofilm structure and microbial adhesion patterns.
Suggested dosing:
Time to relief varies depending on:
In clinical evaluations:
Optimal results require consistency with dosing.
Related Reading:
For many patients, Atrantil provides progressive improvement during the first several weeks.
Some patients may temporarily experience:
These symptoms are hypothesized to reflect microbial shifts and endotoxin exposure as microbial balance changes.
Possible short-lived symptoms may include:
Atrantil can be taken with or without food, although mild stomach discomfort may occur on an empty stomach.
Atrantil’s ingredients primarily act within the gut lumen with minimal systemic absorption due to their large macromolecular structure. The side-effect profile is considered minimal.
Atrantil has not been evaluated in:
As with any supplement, patients with complex medical conditions should consult their healthcare provider.
Clinical Evidence
Atrantil has been evaluated in multiple published clinical studies.
An independent investigator-initiated study reported:
Principal Investigator:Darren Brenner, MD, FACG, AGAF
Published in the Journal of Gastroenterology and Hepatology Research (2015).The study reported:
Published in the World Journal of Gastrointestinal Pharmacology and Therapeutics (2016).Approximately 80% of participants reported improvement in:
Importantly, these participants had previously failed multiple therapies.
Get Introductory Wholesale Pricing
If you are interested in offering patients a:
approach for bloating, methane-associated symptoms, and broader microbiome restoration, we would be happy to send you additional information and set you up with introductory wholesale pricing.
Healthcare Concierge:
Email: Dacia@kbsresearch.com